Cyclo-oxygenase inhibition restores the attenuated vasodilation in manganese-deficient rat aorta

Journal of Nutrition

Volumn 136, Issue 9, 2006, Pages 2302-2307

  Kalea, Anastasia Z ^a   Schuschke, Dale A ^b   Harris, Patrick D ^b   Klimis Zacas, Dorothy J ^a  

^a UNIVERSITY OF MAINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; MANGANESE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DRUG MECHANISM; DRUG RESPONSE; ENZYME INHIBITION; FOOD INTAKE; MALE; NONHUMAN; RAT; VASCULAR RING; VASODILATATION;

EID: 33748335626     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.9.2302     Document Type: Article

References (52)

1. Fleisch JH. Pharmacology of the aorta: a brief review. Blood Vessels. 1974;11:193-211.
2. Lüscher TF, Vanhoutte PM. The endothelium modulator of cardiovascular function. Boca Raton, FL: CRC Press; 1990.
3. Moncada S, Higgs EA. The L-Arginine - Nitric Oxide Pathway. N Engl J Med. 1993;329:2002-12.
4. Russo G, Leopold JA, Loscalzo J. Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis. Vascul Pharmacol. 2002;38:259-69.
5. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev. 2000;52:375-414.
6. Salvemini D, Currie MG, Mollace V. Nitric oxide-mediated cyclooxygenase activation. J Clin Invest. 1996;97:2562-8.
7. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of vascular smooth muscle. Acta Pharmacol Sin. 2000;21:1-18.
8. Boulanger CM. Endothelial dysfunction: a novel therapeutic target: secondary endothelial dysfunction: hypertension and heart failure. J Mol Cell Cardiol. 1999;31:39-49.
9. Mombouli JV, Nakashima M, Hamra M, Vanhoutte PM. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training. Br J Pharmacol. 1999;117:413-8.
10. Shimokawa H. Endothelial dysfunction: a novel therapeutic target: primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol. 1999;31:23-37.
11. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-4.
12. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963-74.
13. Loscalzo J, Vita J. Nitric oxide and the cardiovascular system. Totawa, NJ: Humana Press; 2003.
14. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci. 1999;55:1078-87.
15. John S, Schmieder RE. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens. 2000;18:363-74.
16. Soma M, Izumi Y, Watanabe Y, Kanmatsuse K. A nitric oxide synthesis inhibitor decreased prostaglandin production in rat mesenteric vasculature. Prostaglandins. 1996;51:225-32.
17. Wang W, Diamond SL. Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun. 1997;233:748-51.
18. Laemmel E, Bonnardel-Phu E, Hou X, Seror J, Vicaut E. Interaction between nitric oxide and prostanoids in arterioles of rat cremaster muscle in vivo. Am J Physiol Heart Circ Physiol. 2003;285:H1254-60.
19. Wedler FC. Biochemical and nutritional role of manganese: an overview. In: Klimis-Tavantzis DJ, editor. Manganese in health and disease. 1st ed. Boca Raton, FL: CRC Press; 1994. p.2-37.
20. 1 adrenergic receptor mediated vascular contraction. J Nutr Biochem. 2005;16:44-9.
21. Kalea AZ, Norton C, Klimis-Zacas D. Dietary manganese affects the receptor signaling pathways of the vascular contractile machinery in rat aorta. J Trace Elem Exp Med. 2002;14:16.
22. 1 adrenoreceptor (AR) mediated contraction of vascular smooth muscle (VSM) in rat aorta. 2003 Experimental Biology meeting abstracts [CD ROM]. FASEB J. 2003;17:703.5. Available from: http://select.biosis.org/faseb/eb2003_data/FASEB009311.html.
23. Kasten TP, Settle SL, Misko TP, Currie MG, Nickols GA. Manganese potentiation of nitric-oxide mediated vascular relaxation. Eur J Pharmacol. 1994;253:35-43.
24. Ensunsa JL, Symons JD, Lanoue L, Schrader HR, Keen CL. Reducing arginase activity via dietary manganese enhances endothelium-dependent vasorelaxation of rat aorta. Exp Biol Med. 2004;229:1143-53.
25. Reeves PG, Nielsen FH, Fahey GC. AIN-93 Purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
26. Yang P, Klimis-Tavantzis D. Effects of dietary manganese on arterial glycosaminoglycan metabolism in Sprague-Dawley rats. Biol Trace Elem Res. 1998;64:275-88.
27. Norton CA, Kalea AZ, Harris PD, Klimis-Zacas D. Wild blueberry-rich diets affect the contractile machinery of the vascular smooth muscle in the Sprague-Dawley rat. J Med Food. 2005;8:8-13.
28. Kawabe T, Harris PD, Zakaria EL, Garrison RN. Sepsis alters vessel contraction by adrenoreceptor-induced nitric oxide and prostanoid. J Surg Res. 2003;110:352-9.
29. Kuribayashi R. Effects of Mn and Zn ions on the contraction of smooth muscle of guinea pig taenia coli. Tohoku J Exp Med. 1969;98:241-7.
30. +2. Eur J Pharmacol. 1981;71:1-11.
31. Yan M, Lu Z, Du XJ, Han C. Effects of micromolar concentrations of Mn, Mo, and Si on alpha1-adrenoceptor-mediated contraction in porcine coronary artery. Biol Trace Elem Res. 1998;64:75-87.
32. Yan M, Liu DL, Chua YL, Chen C, Lim YL. Effects of micromolar concentrations of manganese, copper, and zinc on alpha1-adrenoceptormediating contraction in rat aorta. Biol Trace Elem Res. 2001;82:159-66.
33. Kirchgessner M, Heiseke D. Arginase activity in the liver of growing rats with manganese deficiency. Int J Vitam Nutr Res. 1978;48:75-8.
34. Brock AA, Chapman SA, Ulman EA, Wu G. Dietary manganese deficiency decreases rat hepatic arginase activity. J Nutr. 1994;124:340-4.
35. Mihai K, Peto J, Kolthay J, Makary A, Timar S. Balance of prostacyclin and thromboxane in offspring of parents with premature coronary arterial disease. Int J Cardiol. 1992;35:13-8.
36. Akimova EV. Prostacyclin and thromboxane A2 levels in children and adolescents with an inherited predisposition to coronary heart disease: a family study. Coron Artery Dis. 1994;5:761-5.
37. Zidenberg-Cherr S, Keen C, Lonnerdal B, Hurley L. Superoxide dismutase activity and lipid peroxidation in the rat: developmental correlations affected by manganese deficiency. J Nutr. 1983;113:2498-504.
38. Malecki EA, Huttner DL, Greger JL. Manganese status, gut endogenous losses of manganese and antioxidant enzyme activity in rats fed varying levels of manganese and fat. Biol Trace Elem Res. 1994;42:17-29.
39. Malecki EA, Greger JL. Manganese protects against heart mitochondrial lipid peroxidation in rats fed high levels of polyunsaturated fatty acids. J Nutr. 1996;126:27-33.
40. Weaver JA, Maddox JF, Cao YZ, Mullarky IK, Sordillo LM. Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells. Free Radic Biol Med. 2001;30:299-308.
41. Kato T, Iwama Y, Okumura K, Hashimoto H, Ito T, Satake T. Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension. 1990;15:475-81.
42. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29: Part2:274-9.
43. Gorelik O, Almoznino-Sarafian D, Feder I, Wachsman O, Alon I, Litvinjuk V, Roshovsky M, Modai D, Cohen N. Dietary intake of various nutrients in older patients with congestive heart failure. Cardiology. 2003;99:177-81.
44. Volkov NF. The cobalt, manganese and zinc content in the blood and internal organs of atherosclerotic patients. Ter Arkh. 1962;34:52-6.
45. Temple NJ. Refined carbohydrates - A cause of suboptimal nutrient intake. Med Hypotheses. 1983;10:411-24.
46. Kies C. Bioavailability of manganese. In: Klimis-Tavantzis D, editor. Manganese in health and disease. 1st ed. Boca Raton, FL: CRC Press; 1994. p.39-58.
47. Patel BD, Welch AA, Bingham SA, Luben RN, Day NE, Khaw KT, Lomas DA, Wareham NJ. Dietary antioxidants and asthma in adults. Thorax. 2006;61:388-93.
48. Carl GF, Keen CL, Gallagher BB, Clegg MS, Littleton WH, Flanner DB, Hurley LS. Association of low blood manganese concentrations with epilepsy. Neurology. 1986;36:1584-7.
49. Cotzias GC, Papavassiliou PS, Hughes ER, Tang L, Borg DC. Slow turnover of manganese in active rheumatoid arthritis accelerated by prednisone. J Clin Invest. 1968;47:992-1001.
50. Ryan DE, Holzbecher J, Stuart DC. Trace elements in scalp-hair of persons with multiple sclerosis and of normal individuals. Clin Chem. 1978;24:1996-2000.
51. Korc M. Manganese as a modulator of signal transduction pathways. In: Prassad AS, editor. Essential and toxic trace elements in human health and disease: an update. New York: Willey-Liss, Inc.; 1993. p.235-255.
52. Edwards JG, Hameed H, Campbell G. Induction of fibroplast spreading by Mn12: apossible role for unusual binding sites for divalent cations in receptors for proteins containing Arg-Gly-Asp. J Cell Sci. 1988;89:507-13.